Molecure S.A. (WSE:MOC)

Molecure Statistics

Total Valuation

Molecure has a market cap or net worth of PLN 123.82 million. The enterprise value is 106.95 million.

Market Cap	123.82M
Enterprise Value	106.95M

Important Dates

The last earnings date was Monday, October 27, 2025.

Earnings Date	Oct 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Molecure has 20.60 million shares outstanding. The number of shares has increased by 36.78% in one year.

Current Share Class	20.60M
Shares Outstanding	20.60M
Shares Change (YoY)	+36.78%
Shares Change (QoQ)	-19.11%
Owned by Insiders (%)	0.90%
Owned by Institutions (%)	11.15%
Float	19.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.14
PB Ratio	1.38
P/TBV Ratio	5.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.38
EV / Sales	18.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.08

Financial Position

The company has a current ratio of 5.93, with a Debt / Equity ratio of 0.06.

Current Ratio	5.93
Quick Ratio	5.76
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.11
Interest Coverage	-502.09

Financial Efficiency

Return on equity (ROE) is -28.81% and return on invested capital (ROIC) is -17.55%.

Return on Equity (ROE)	-28.81%
Return on Assets (ROA)	-17.15%
Return on Invested Capital (ROIC)	-17.55%
Return on Capital Employed (ROCE)	-27.25%
Revenue Per Employee	82,492
Profits Per Employee	-343,932
Employee Count	102
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.81% in the last 52 weeks. The beta is 0.81, so Molecure's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-46.81%
50-Day Moving Average	7.06
200-Day Moving Average	7.53
Relative Strength Index (RSI)	26.04
Average Volume (20 Days)	35,954

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Molecure had revenue of PLN 5.86 million and -24.42 million in losses. Loss per share was -1.06.

Revenue	5.86M
Gross Profit	3.38M
Operating Income	-25.37M
Pretax Income	-24.42M
Net Income	-24.42M
EBITDA	-24.30M
EBIT	-25.37M
Loss Per Share	-1.06

Balance Sheet

The company has 22.46 million in cash and 5.58 million in debt, giving a net cash position of 16.88 million or 0.82 per share.

Cash & Cash Equivalents	22.46M
Total Debt	5.58M
Net Cash	16.88M
Net Cash Per Share	0.82
Equity (Book Value)	89.43M
Book Value Per Share	4.34
Working Capital	19.97M

Cash Flow

In the last 12 months, operating cash flow was -51.39 million and capital expenditures -39,932, giving a free cash flow of -51.43 million.

Operating Cash Flow	-51.39M
Capital Expenditures	-39,932
Free Cash Flow	-51.43M
FCF Per Share	-2.50

Margins

Gross Margin	57.65%
Operating Margin	-433.14%
Pretax Margin	-416.93%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Molecure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.78%
Shareholder Yield	-36.78%
Earnings Yield	-19.72%
FCF Yield	-41.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Molecure has an Altman Z-Score of 10.21 and a Piotroski F-Score of 2.

Altman Z-Score	10.21
Piotroski F-Score	2